Skip to main content

Animations

Miratul Muqit, MD, PhD

Professor of Experimental Neurology at MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee
Location: Dundee United Kingdom

Miratul Muqit, MD, PhD, has made major contributions to understanding how two Parkinson’s disease-linked genes, PINK1 and Parkin, function together in removing damaged mitochondria by autophagy or ‘mitophagy’. The molecular mechanisms elucidated by his research group have contributed to the development of targeted therapies for mitophagy that entered clinical trials last year for Parkinson’s patients. He studied Medicine at the University of Edinburgh and was a Kennedy Scholar at Harvard University before completing a PhD at UCL. He is currently Professor of Experimental Neurology and Aligning Science Across Parkinson’s (ASAP) Co-Investigator at the MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee. He was elected an EMBO Young Investigator in 2017, Fellow of the Royal Society of Edinburgh in 2020, and Fellow of Academy Medical Sciences in 2023.

 


Associated Grants

  • Role of TFEB Pathway Activators and ISR Inhibitors on Alpha-synuclein Associated Impaired Mitophagy in the a Pre-clinical Model Brain

    2025


  • Characterization of a Preclinical Model Bearing a Parkinson’s Disease–linked Mutation in PLA2G6

    2024


  • Mapping the LRRK2 Signaling Pathway and Uncovering Its Interplay with Other Molecular Components of Parkinson’s Disease

    2024


  • Development of an Antibody for Isolating Mitochondria from Preclinical Models and Individuals with Parkinson’s Disease

    2022


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.